Streetbeat News

Price Targets

H

Truist Securities maintains a Buy rating on Hyatt Hotels but lowers the price target from $168 to $164.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:08 pm

GPOR

Truist Securities has maintained its Buy rating on Gulfport Energy and raised the price target from $194 to $198.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:06 pm

GSBD

Truist Securities analyst Mark Hughes maintains a Hold rating on Goldman Sachs BDC (NYSE:GSBD) and lowers the price target from $16 to $14.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:04 pm

ARDT

Loop Capital has initiated coverage on Ardent Health Partners (NYSE:ARDT) with a Buy rating and set a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:01 pm

STEP

StepStone Group (NASDAQ:STEP) has been analyzed by 6 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has increased by 12.5% to $46.17. Analysts have recently raised their price targets, reflecting positive sentiment. The company has shown positive revenue growth but faces challenges in net margin and asset utilization.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 1:01 pm

CLSK

In the last three months, 6 analysts have published ratings on Cleanspark (NASDAQ:CLSK), showing a range of perspectives from bullish to bearish. The average 12-month price target is $24.08, with a high of $28.00 and a low of $12.50. Recent analyst actions include both raises and lowers in price targets, reflecting changing market conditions and company performance. Cleanspark has shown impressive financial metrics, including a revenue growth rate of 162.77%, a net margin of 110.82%, and a return on equity of 10.9%.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 1:01 pm

CRSP

Truist Securities maintains a Buy rating on CRISPR Therapeutics but lowers the price target from $120 to $100.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:01 pm

CPRX

Analysts have recently evaluated Catalyst Pharmaceuticals (NASDAQ:CPRX) with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased by 9.77% to $29.2. Key analysts from firms like HC Wainwright & Co., Citigroup, Truist Securities, and Oppenheimer have raised their price targets, reflecting positive sentiment towards the company's future performance.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 1:00 pm

MUR

In the last three months, 4 analysts have published ratings on Murphy Oil (NYSE:MUR), showing a range of perspectives from bullish to bearish. The average 12-month price target is $50.5, with a high of $55.00 and a low of $46.00. Recent analyst actions include lowering ratings and price targets, reflecting changing market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 1:00 pm

CARG

CarGurus (NASDAQ:CARG) has received mixed ratings from 9 analysts over the past three months, with a recent trend towards more bullish perspectives. The average 12-month price target has increased to $29.78, reflecting a 7.82% rise from the previous target. Analysts have raised their ratings and price targets, indicating a positive outlook despite the company's recent revenue decline and below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 1:00 pm